13F Filings History of Mondrian Investment Partners LTD

Latest 13F report
Q4 2025 - 09 Feb 2026
Value $
$6,060,586,005
Signature - Title
Ed Lambert - Chief Compliance Officer
Location
London, United Kingdom
Summary
This page shows a list of all the recent 13F filings made by Mondrian Investment Partners LTD. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Mondrian Investment Partners LTD reported 102 stock holdings with total value $6,060,586,005 as of Q4 2025. Top holdings included LYG, SAN, GSK, SONY, and SNY.

Notify me when Mondrian Investment Partners LTD files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q4 2025 102 $6,060,586,005 +$444,597,214 -$629,778,762 -$185,181,548 LYG, SAN, GSK, SONY, SNY 13F-HR 09 Feb 2026, 09:25
Q3 2025 97 $5,989,589,083 +$766,544,219 -$1,462,010,463 -$695,466,244 LYG, SAN, SONY, GSK, BTI 13F-HR 07 Nov 2025, 10:57
Q1 2025 98 $5,846,190,596 +$241,415,415 -$336,035,230 -$94,619,815 SAN, LYG, SONY, TRP, BTI 13F-HR 13 May 2025, 07:28
Q4 2024 101 $5,751,690,899 +$985,722,765 -$1,031,409,966 -$45,687,201 SONY, LYG, SAN, GSK, PHG Restatement 13 Feb 2025, 13:54
Q3 2024 102 $6,198,302,553 +$158,783,839 -$407,837,402 -$249,053,563 PHG, LYG, SAN, SONY, GSK 13F-HR 05 Nov 2024, 11:55
Q2 2024 98 $6,095,623,256 +$541,317,317 -$1,406,850,980 -$865,533,663 PHG, LYG, SAN, SONY, GSK 13F-HR 12 Aug 2024, 07:46
Q1 2024 100 $6,788,658,593 +$1,213,717,551 -$367,003,224 +$846,714,327 SAN, TSM, GSK, LYG, BP 13F-HR 07 May 2024, 09:59
Q4 2023 100 $5,537,131,917 +$1,448,846,004 -$394,662,316 +$1,054,183,688 BAP, SAN, SONY, MSFT, DLTR 13F-HR 13 Feb 2024, 09:00
Q3 2023 91 $4,184,041,010 +$259,710,296 -$713,661,817 -$453,951,521 BAP, PBR, ATHM, ABBV, MSFT 13F-HR 06 Nov 2023, 09:20
Q2 2023 88 $5,001,518,315 +$509,038,556 -$328,636,927 +$180,401,629 TRP, BAP, MSFT, META, PBR Restatement 20 Sep 2023, 12:45
Q1 2023 90 $4,531,769,668 +$178,200,491 -$342,538,205 -$164,337,714 BAP, MSFT, ATHM, TRP, META Restatement 20 Sep 2023, 14:00
Q4 2022 93 $4,298,781,000 +$349,668,156 -$371,150,360 -$21,482,204 BAP, ATHM, BIDU, GOLD, VALE 13F-HR 03 Feb 2023, 09:58
Q3 2022 84 $3,883,059,000 +$465,493,852 -$363,059,664 +$102,434,188 BAP, BIDU, ATHM, WMT, MSFT 13F-HR 21 Oct 2022, 12:48
Q2 2022 80 $4,159,397,000 +$425,107,306 -$229,514,823 +$195,592,483 ATHM, BIDU, BAP, ABBV, MSFT 13F-HR 09 Aug 2022, 12:26
Q1 2022 125 $4,426,481,000 +$396,516,147 -$1,055,538,145 -$659,021,998 BIDU, BAP, ATHM, MSFT, PGR 13F-HR 05 May 2022, 11:13
Q4 2021 130 $4,981,571,000 +$504,468,129 -$599,549,593 -$95,081,464 BIDU, BAP, MSFT, CNC, TSM 13F-HR 09 Feb 2022, 09:03
Q3 2021 123 $4,819,566,000 +$408,483,280 -$442,122,045 -$33,638,765 BIDU, BAP, TSM, ATHM, MSFT 13F-HR 27 Oct 2021, 11:38
Q2 2021 123 $5,096,503,000 +$751,354,888 -$212,744,809 +$538,610,079 BIDU, TSM, ATHM, BAP, INFY 13F-HR 30 Jul 2021, 07:17
Q1 2021 120 $4,492,781,000 +$1,026,694,513 -$714,763,453 +$311,931,060 BIDU, TSM, ATHM, INFY, WFC 13F-HR 10 May 2021, 09:53
Q4 2020 110 $3,925,019,000 +$643,642,889 -$116,890,906 +$526,751,983 BIDU, TSM, INFY, BAP, JNJ 13F-HR 11 Feb 2021, 07:16
Q3 2020 105 $2,767,505,000 +$361,732,856 -$243,483,498 +$118,249,358 BIDU, INFY, TSM, YUMC, GOLD 13F-HR 13 Nov 2020, 11:33
Q2 2020 116 $2,679,692,000 +$501,297,166 -$998,558,170 -$497,261,004 TSM, BIDU, INFY, NTES, YUMC 13F-HR 10 Aug 2020, 10:46
Q1 2020 112 $2,744,366,000 +$247,298,133 -$279,212,527 -$31,914,394 BABA, NTES, TSM, INFY, JNJ 13F-HR 12 May 2020, 12:47
Q4 2019 125 $3,625,962,000 +$537,628,440 -$112,852,909 +$424,775,531 BABA, ERJ, NTES, TSM, INFY 13F-HR 06 Feb 2020, 10:50
Q3 2019 125 $2,911,292,000 +$336,276,540 -$357,248,565 -$20,972,025 BABA, ERJ, TSM, INFY, ITUB 13F-HR 04 Nov 2019, 10:10
Q2 2019 124 $2,962,715,000 +$210,496,060 -$253,607,608 -$43,111,548 ERJ, BABA, ITUB, TSM, JNJ 13F-HR 07 Aug 2019, 11:45
Q1 2019 127 $3,010,800,000 +$392,362,515 -$106,950,381 +$285,412,134 ERJ, BABA, TSM, ITUB, BAP 13F-HR 17 Apr 2019, 14:17
Q4 2018 128 $2,515,324,000 +$208,050,667 -$356,004,342 -$147,953,675 ERJ, TSM, ITUB, BAP, JNJ 13F-HR 24 Jan 2019, 07:08
Q3 2018 122 $2,915,661,000 +$187,442,014 -$338,039,920 -$150,597,906 ERJ, TSM, ITUB, BAP, MSFT 13F-HR 01 Nov 2018, 13:29
Q2 2018 125 $3,053,413,000 +$124,190,434 -$253,419,977 -$129,229,543 ERJ, TSM, ITUB, BAP, MSFT 13F-HR 25 Jul 2018, 06:44
Q1 2018 130 $3,326,103,000 +$155,555,844 -$549,106,158 -$393,550,314 ERJ, ITUB, TSM, BAP, PHI 13F-HR 11 May 2018, 06:51
Q4 2017 138 $3,679,411,000 +$522,786,589 -$403,363,581 +$119,423,008 ERJ, ITUB, TSM, BAP, PHI 13F-HR 18 Jan 2018, 10:25
Q3 2017 134 $3,497,254,000 +$667,003,230 -$395,626,145 +$271,377,085 TSM, ERJ, ITUB, BAP, ABEV 13F-HR 02 Nov 2017, 07:17
Q2 2017 136 $3,070,273,000 +$251,035,474 -$441,393,267 -$190,357,793 TSM, BAP, PHI, ABEV, BSMX 13F-HR 02 Aug 2017, 10:48
Q1 2017 138 $3,157,263,000 +$461,883,126 -$611,091,128 -$149,208,002 TSM, PHI, BAP, ABEV, BSMX 13F-HR 26 Apr 2017, 10:30
Q4 2016 136 $3,096,366,000 +$108,078,488 -$462,244,919 -$354,166,431 BAP, ABT, PHI, TSM, ABEV 13F-HR 03 Feb 2017, 09:21
Q3 2016 135 $3,540,654,000 +$506,194,908 -$794,677,260 -$288,482,352 BAP, ABT, PHI, TSM, ABEV 13F-HR 08 Nov 2016, 11:03
Q2 2016 136 $3,708,069,000 +$237,437,577 -$659,706,814 -$422,269,237 BAP, ABT, PHI, BSMX, TSM 13F-HR 01 Aug 2016, 12:00
Q1 2016 139 $4,032,732,000 +$575,009,704 -$894,481,239 -$319,471,535 YUM, BAP, ABT, PHI, BSMX 13F-HR 04 May 2016, 10:02
Q4 2015 143 $4,326,910,000 +$198,840,714 -$528,219,405 -$329,378,691 MR, YUM, PHI, CAE, BAP 13F-HR 13 Jan 2016, 10:05
Q3 2015 142 $4,305,435,000 +$295,015,888 -$772,741,851 -$477,725,963 YUM, TEVA, PHI, MR, BAP 13F-HR 20 Oct 2015, 09:55
Q2 2015 97 $5,488,391,000 +$224,237,877 -$436,445,156 -$212,207,279 TEVA, YUM, PHI, MR, BAP 13F-HR 27 Jul 2015, 11:22
Q1 2015 89 $5,779,466,000 +$238,911,695 -$292,217,467 -$53,305,772 TEVA, YUM, PHI, MR, ENIAY Restatement 10 Aug 2015, 10:11
Q4 2014 90 $6,205,438,000 +$408,833,792 -$576,202,583 -$167,368,791 TEVA, YUM, PHI, BAP, MR 13F-HR 27 Jan 2015, 12:42
Q3 2014 88 $6,566,005,000 +$151,305,886 -$549,606,258 -$398,300,372 TEVA, YUM, PHI, BAP, MR 13F-HR 22 Oct 2014, 09:49
Q2 2014 90 $7,123,873,000 +$445,985,089 -$363,341,295 +$82,643,794 TEVA, YUM, PHI, BAP, VALEP 13F-HR 04 Aug 2014, 10:33
Q1 2014 90 $6,803,978,000 +$222,503,394 -$832,744,966 -$610,241,572 TEVA, YUM, VALEP, MR, PHI 13F-HR 15 Apr 2014, 07:25
Q4 2013 88 $7,143,152,000 $0 $0 $0 TEVA, YUM, MR, VALEP, BSMX 13F-HR 07 Jan 2014, 07:43